{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:55:07Z","timestamp":1790603707014,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Kidney transplantation remains the most effective treatment for end-stage kidney disease; however, long-term graft survival is constrained by rejection and chronic graft injury, and donor shortages continue to drive interest in xenotransplantation. The complement system is increasingly recognized both as a terminal effector of antibody-mediated injury and as a regulatory network linking antibody responses, endothelial activation, ischemia\u2013reperfusion injury, coagulation, and innate immune cell responses. In this review, we compare the role of complement in allogeneic and xenogeneic kidney transplantation and provide an overview of emerging therapeutic strategies. In allogeneic transplantation, donor-specific anti-HLA and anti-ABO blood group antibodies activate complement, particularly via the classical pathway, and contribute to antibody-mediated rejection. Although C4d deposition is a key marker of complement activation, its clinical significance depends on the presence of microvascular inflammation, endothelial injury, and other immune mechanisms. Complement-binding donor-specific antibodies may improve risk stratification, whereas the clinical benefits of inhibiting C5, C3, and upstream complement in chronic active antibody-mediated rejection remain uncertain. In xenotransplantation, \u03b1-Gal and non-Gal antigens, their corresponding natural antibodies, complement activation via the classical, lectin, and alternative pathways, and interspecies incompatibilities in complement regulation collectively promote vascular endothelial injury and thromboinflammation. Multiplex genetic modification of donor pigs, including deletion of major carbohydrate antigens and expression of human complement and coagulation regulatory proteins, has substantially mitigated hyperacute rejection. However, achieving durable xenograft survival requires effective control of macrophages, natural killer cells, neutrophils, and their interactions with the graft endothelium. Therefore, integrated strategies combining genetic complement regulation, pharmacological complement inhibition, coagulation regulation, and innate immune modulation may be essential for preventing chronic allograft injury and improving long-term kidney xenograft survival.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1961041","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:57:57Z","timestamp":1790600277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Complement system in kidney transplantation: from innate immune surveillance to a therapeutic and genetic engineering target"],"prefix":"10.3389","volume":"17","author":[{"given":"Yoichi","family":"Kakuta","sequence":"first","affiliation":[{"name":"Department of Urology, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Ikawa","sequence":"additional","affiliation":[{"name":"Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Nonomura","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Osaka Graduate School of Medicine","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ajt.2025.01.020","article-title":"OPTN\/SRTR 2023 annual data report: Kidney","volume":"25","author":"Lentine","year":"2025","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1865","article-title":"Rate of deceased kidney donation from potential in-hospital deaths in the US, 2003-2021","volume":"7","author":"Bragg-Gresham","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0071-x","article-title":"The multifaceted role of complement in kidney transplantation","volume":"14","author":"Biglarnia","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02380","article-title":"The role of complement in organ transplantation","volume":"10","author":"Grafals","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00624-6","article-title":"Progress in xenotransplantation: overcoming immune barriers","volume":"18","author":"Sykes","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf224","article-title":"Antibody-mediated rejection in ABO-incompatible kidney transplantation","volume":"41","author":"Castrezana Lopez","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00791-0","article-title":"Translating B cell immunology to the treatment of antibody-mediated allograft rejection","volume":"20","author":"Heeger","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.04.023","article-title":"A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients","volume":"108","author":"Mulley","year":"2025","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860165","article-title":"Aspects of the complement system in new era of xenotransplantation","volume":"13","author":"Miyagawa","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2120238","article-title":"Results of two cases of pig-to-human kidney xenotransplantation","volume":"386","author":"Montgomery","year":"2022","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2412747","article-title":"Xenotransplantation of a porcine kidney for end-stage kidney disease","volume":"392","author":"Kawai","year":"2025","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.858604","article-title":"The innate cellular immune response in xenotransplantation","volume":"13","author":"Maeda","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08713-9","article-title":"Granzyme K activates the entire complement cascade","volume":"641","author":"Donado","year":"2025","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13144","article-title":"Local complement synthesis-A process with near and far consequences for ischemia reperfusion injury and transplantation","volume":"313","author":"Nauser","year":"2023","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2025.100981","article-title":"Research progress on the complement system in ischemia-reperfusion injury of organ transplantation","volume":"40","author":"Zhang","year":"2026","journal-title":"Transplant Rev (Orlando)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12471","article-title":"Dangerous liaisons: complement, coagulation, and kallikrein\/kinin cross-talk act as a linchpin in the events leading to thromboinflammation","volume":"274","author":"Ekdahl","year":"2016","journal-title":"Immunol Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.07.023","article-title":"The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation","volume":"25","author":"Nankivell","year":"2025","journal-title":"Am J Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular Inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00179.x","article-title":"Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury","volume":"3","author":"Park","year":"2003","journal-title":"Am J Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2019.03.05","article-title":"Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience","volume":"8","author":"Okumi","year":"2019","journal-title":"Transl Androl Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001403","article-title":"Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation","volume":"101","author":"Ishihara","year":"2017","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020010019","article-title":"Eplet mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, rejection, and graft failure after kidney transplantation: An observational cohort study","volume":"31","author":"Senev","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020040433","article-title":"Missing Self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection","volume":"32","author":"Koenig","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13871","article-title":"Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study","volume":"16","author":"Montgomery","year":"2016","journal-title":"Am J Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15464","DOI":"10.1038\/s41598-021-94954-3","article-title":"Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants","volume":"11","author":"Vonbrunn","year":"2021","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148881","article-title":"Depression of complement regulatory factors in rat and human renal grafts is associated with the progress of acute T-cell mediated rejection","volume":"11","author":"Yamanaka","year":"2016","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2019070651","article-title":"Clinical pig kidney xenotransplantation: How close are we","volume":"31","author":"Cooper","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/xen.12161","article-title":"Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1\/CMAH\/\u03b24GalNT2 genes","volume":"22","author":"Estrada","year":"2015","journal-title":"Xenotransplantation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/xen.70115","article-title":"Impact of gene duplication of B4GALNT2 in pigs for xenotransplantation- technical & practical","volume":"33","author":"Lucas","year":"2026","journal-title":"Xenotransplantation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2005.00209.x","article-title":"Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor","volume":"12","author":"Zhou","year":"2005","journal-title":"Xenotransplantation"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27506","article-title":"Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation-A narrative review","volume":"100","author":"Zidan","year":"2025","journal-title":"Am J Hematol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e3283446c65","article-title":"Controlling coagulation dysregulation in xenotransplantation","volume":"16","author":"Cowan","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12173","article-title":"Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response","volume":"22","author":"Kim","year":"2015","journal-title":"Xenotransplantation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609661104","article-title":"Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages","volume":"104","author":"Ide","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01622.x","article-title":"The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis","volume":"126","author":"Matsunami","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200205270-00010","article-title":"Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis","volume":"73","author":"Matsunami","year":"2002","journal-title":"Transplantation"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1546-2","article-title":"Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis","volume":"48","author":"Sakai","year":"2018","journal-title":"Surg Today"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.07.008","article-title":"Human TIGIT on porcine aortic endothelial cells suppresses xenogeneic macrophage-mediated cytotoxicity","volume":"224","author":"Noguchi","year":"2019","journal-title":"Immunobiology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12396","article-title":"Human CD31 on porcine cells suppress xenogeneic neutrophil-mediated cytotoxicity via the inhibition of NETosis","volume":"25","author":"Wang","year":"2018","journal-title":"Xenotransplantation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001175","article-title":"The regulation of neutrophil extracellular trap-induced tissue damage by human CD177","volume":"7","author":"Yoneyama","year":"2021","journal-title":"Transplant Direct"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102020","article-title":"The hybrid CL-SP-D molecule has the potential to regulate xenogeneic rejection by human neutrophils more efficiently than CD47","volume":"84","author":"Iemitsu","year":"2024","journal-title":"Transpl Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/xen.70087","article-title":"Complement inhibition in xenotransplantation\u2014Where should the complement cascade be inhibited","volume":"32","author":"Maenaka","year":"2025","journal-title":"Xenotransplantation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175996","article-title":"C5 inhibition with eculizumab prevents thrombotic microangiopathy in a case series of pig-to-human kidney xenotransplantation","volume":"134","author":"Jones-Carr","year":"2024","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1961041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:57:58Z","timestamp":1790600278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1961041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2026.1961041"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1961041","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1961041"}}